Getting under your skin: deep visual proteomics for investigating cutaneous adverse drug reactions

Thierry Nordmann (left) is a clinician-scientist and dermatologist with a focus on inflammatory cutaneous disorders. He completed his PhD after his medical studies, investigating anti-inflammatory treatment strategies for type 2 diabetes. Following his training as a dermatologist, Nordmann joined the renowned research group of Matthias Mann at the Max Planck Institute of Biochemistry (Munich, Germany) and has since applied cutting-edge proteomic technologies to gain translational insights into skin diseases. In this interview from ELRIG Research & Innovation (20–21 March 2024; Manchester, UK), we learned more about the novel technologies Nordmann and colleagues have developed to investigate skin diseases. What is...